<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="utf-8">
    <title>achingerlab.com</title>
    <meta content="width=device-width, initial-scale=1.0" name="viewport">
    <meta content="" name="keywords">
    <meta content="" name="description">

    <!-- Favicon -->
    <link href="img/favicon.ico" rel="icon">

    <!-- Google Web Fonts -->
    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    <link href="https://fonts.googleapis.com/css2?family=Roboto:wght@400;500&family=Red+Rose:wght@600;700&display=swap"
        rel="stylesheet">

    <!-- Icon Font Stylesheet -->
    <link href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.10.0/css/all.min.css" rel="stylesheet">
    <link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/bootstrap-icons@1.10.4/font/bootstrap-icons.css">

    <!-- Libraries Stylesheet -->
    <link href="lib/animate/animate.min.css" rel="stylesheet">
    <link href="lib/owlcarousel/assets/owl.carousel.min.css" rel="stylesheet">

    <!-- Customized Bootstrap Stylesheet -->
    <link href="css/bootstrap.min.css" rel="stylesheet">

    <!-- Template Stylesheet -->
    <link href="css/style.css" rel="stylesheet">
</head>

<body>




  <div id="spinner" class="show bg-white position-fixed translate-middle w-100 vh-100 top-50 start-50 d-flex align-items-center justify-content-center">
    <div class="spinner-border text-primary" role="status" style="width: 3rem; height: 3rem;"></div>
</div>

<div class="container">
    <nav class="navbar navbar-expand-lg navbar-light bg-white py-lg-0 px-lg-3">
        <button type="button" class="navbar-toggler me-0" data-bs-toggle="collapse" data-bs-target="#navbarCollapse">
            <span class="navbar-toggler-icon"></span>
        </button>
        <div class="collapse navbar-collapse" id="navbarCollapse">
            <div class="navbar-nav">
                <a href="index.html" class="nav-item nav-link active">Home</a>
                <div class="nav-item dropdown">
                    <a href="#" class="nav-link dropdown-toggle" data-bs-toggle="dropdown">Team</a>
                    <div class="dropdown-menu bg-light m-0">
                        <a href="AboutJo.html" class="dropdown-item">About Jo</a>
                        <a href="CurrentTeam.html" class="dropdown-item">Current Team</a>
                        <a href="JoinUs.html" class="dropdown-item">Join Us</a>
                    </div>
                </div>
                <a href="Projects.html" class="nav-item nav-link">Projects</a>
                <a href="Publications.html" class="nav-item nav-link">Publications</a>
                <a href="Funding.html" class="nav-item nav-link">Funding</a>
                <a href="Contact.html" class="nav-item nav-link">Contact</a>
            </div>
            <div class="ms-auto d-none d-lg-flex">
                <a class="btn btn-sm-square btn-primary ms-2" href="https://x.com/aachinger"><i class="fab fa-twitter"></i></a>
            </div>
        </div>
    </nav>
</div>

<div class="container-fluid py-2 d-none d-lg-flex">
    <div class="container">
        <div class="d-flex justify-content-between">
            <div>
                <small class="me-3"><i class="f"></i></small>
                <small class="me-3"><i class=""></i></small>
            </div>
        </div>
    </div>
</div>

<div class="container-fluid page-header py-5 wow fadeIn" data-wow-delay="0.1s">
    <div class="container text-center py-5 mt-4">
        <h1 class="display-2 text-white mb-3 animated slideInDown">3D Chromatin Organisation Lab</h1>
    </div>
</div>

	 <div class="container-fluid container-team py-5">
        <div class="container pb-5">
          <div class="wow fadeIn" data-wow-delay="0.5s">
              <h1 class="display-6 mb-3">Current Projects</h1>
              <p class="mb-4"><strong>EXPLORING THE CONTRIBUTION OF TRANSPOSABLE ELEMENTS TO GENE DEREGULATION IN CANCER</strong></p>
              <p class="mb-4">Transposable elements (TEs), known as “jumping genes”, are mobile DNA elements that have expanded within the genome throughout evolution and constitute over 50% of the human genome.&nbsp;</p>
              <p class="mb-4">Epigenetic dysregulations are hallmarks of cancer and that provides a particularly fertile ground for TE activation.&nbsp; TEs reactivated in cancer can serve as regulatory elements, including promoters and enhancers, triggering oncogenic transcriptional response.&nbsp; In contrast, induction of TEs through genome-wide epigenetic changes in cancer cells could also potentially trigger anti-tumour immune responses leading to the destruction of cancer cells via “viral mimicry".&nbsp;&nbsp;</p>
              <p class="mb-4">The primary objective of this research is to comprehensively delineate the molecular and cellular functions of TEs in the regulatory cancer genome and characterise the epigenetic mechanisms that define their diverse activities. The key aims are to:</p>
              <p class="mb-4">&nbsp;• Identify and characterize regulatory TEs across all cancer sub-types in TCGA and determine their transcriptional effects</p>
              <p class="mb-4">&nbsp;• Explore how these regulatory TEs contribute to cancer cellular phenotypes using models of TE activation in cancer</p>
              <p class="mb-4">&nbsp;• Identify chromatin variants and transcription factors involved in TE regulation and assess their potential for targeting in cancer. &nbsp;</p>
<img class="img-fluid w-100" src="img/projects.png" alt="">
            <p class="mb-4">&nbsp;</p>
              <p class="mb-4"><strong>TARGETING REGULATORY TRANSPOSABLE ELEMENTS IN CDK4/6 INHIBITORS RESISTANT  BREAST CANCER </strong></p>
              <p class="mb-4">Inhibitors of cyclin-dependant kinases 4 and 6 (CDK4/6i) are now standard of care treatment of metastatic estrogen receptor-positive (ER+) breast cancer. It is expected that all patients with advanced ER+ breast cancer will receive CDK4/6i. However, eventual treatment failure is unfortunately inevitable. No clear second-line treatment strategy exists following the development of CDK4/6i resistance. The widespread emergence of resistance to CDK4/6i is therefore poised to become the major challenge for the management of metastatic ER+ breast cancer.&nbsp;</p>
              <p class="mb-4">The TP53 tumour suppressor gene, known as the “guardian of the genome”, is the most frequently altered gene in cancer. It encodes for a transcription factor p53 that triggers a transcriptional program to control cellular stress response. The control of TEs is an important component of p53's function as the guardian of the genome and p53 reactivation is a promising anticancer strategy.&nbsp;&nbsp;</p>
<p class="mb-4">Using in vitro and in vivo pre-clinical models we are uncovering the molecular mechanisms of CDK4/6i resistance and&nbsp;testing if therapeutic targeting of TEs via p53 activation can restore sensitivity and prolong response to CDK4/6 inhibitors in our established cell lie&nbsp; and  PDX models.&nbsp;</p>
<img class="img-fluid w-100" src="img/projects2.png" alt="">
              
<p class="mb-4">&nbsp;</p>
<p class="mb-4">&nbsp;<strong>ELUCIDATING THE ROLE OF 3D GENOME STRUCTURE IN LINEAGE PLASTICITY IN CANCER</strong></p>
<p class="mb-4">Cell lineage plasticity is recognized as a novel mechanism of tumor progression and treatment resistance in cancer. It is mainly driven by dynamic transcriptional and epigenetic changes, however the role of 3D genome structure alterations in driving lineage plasticity is not yet fully understood. Understanding the key 3D genome structure, epigenetic and transcriptional regulators of cancer cell plasticity&nbsp;can yield new avenues for therapy.</p>
<p class="mb-4"><img class="img-fluid w-100" src="img/projects3.png" alt=""></p>
<p class="mb-4"><strong>DEVELOPMET&nbsp;AND OPTIMAZATION OF THE SINGLE-CELL Hi-C TECHNOLOGY</strong></p>
<p class="mb-4">Cellular heterogeneity is a major problem in cancer therapy, as treatment-resistant cells can promote relapse. The advent of single-cell genomics techniques allows the determination of epigenetic and transcriptional profiles of these treatment-resistant populations. By developing new methods to study and integrate the 3D genome, epigenetic and transcriptomics datasets from single-cells, we aim to further understand&nbsp;the molecular mechanisms of treatment resistance and identify new avenues for therapy to target the entire tumour population, or in combination with existing therapies.</p>
<p class="mb-4">&nbsp;</p>
<div class="d-flex"> <a class="btn btn-lg-square btn-primary me-2" href="https://x.com/aachinger"><i class="fab fa-twitter"></i></a> </div>
            </div>
            <div class="row g-5 align-items-center mb-5">
                <div class="col-md-6 wow fadeIn" data-wow-delay="0.3s"> </div>
</div>
</div>
            </div>
	

<div class="container-fluid copyright bg-dark text-white-50 py-4">
    <div class="container">
        <div class="row">
            <div class="col-md-6 text-center text-md-start">
                <p class="mb-0">&copy; <a href="#">achingerlab.com</a>. All Rights Reserved.</p>
            </div>
            <div class="col-md-6 text-center text-md-end"> </div>
        </div>
    </div>
</div>



    <!-- Back to Top -->
    <a href="#" class="btn btn-lg btn-primary btn-lg-square rounded-circle back-to-top"><i class="bi bi-arrow-up"></i></a>


    <!-- JavaScript Libraries -->
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/3.6.1/jquery.min.js"></script>
    <script src="https://cdn.jsdelivr.net/npm/bootstrap@5.0.0/dist/js/bootstrap.bundle.min.js"></script>
    <script src="lib/wow/wow.min.js"></script>
    <script src="lib/easing/easing.min.js"></script>
    <script src="lib/waypoints/waypoints.min.js"></script>
    <script src="lib/counterup/counterup.min.js"></script>
    <script src="lib/owlcarousel/owl.carousel.min.js"></script>

    <!-- Template Javascript -->
    <script src="js/main.js"></script>
</body>

</html>
